Literature DB >> 33835456

Exploring Noninvasive Biomarkers with the miRandola Database: A Tool for Translational Medicine.

Francesco Russo1.   

Abstract

Noninvasive biomarkers are required for addressing crucial clinical needs. The ideal biomarker should be easily accessible and provide a unique characteristic for a healthy status or a pathological condition. In the last years, microRNAs (miRNAs) have been proposed as promising tissue-based biomarkers for several diseases such as cancer and cardiovascular diseases. Recently, miRNAs have shown great potential as novel noninvasive biomarkers, due to their high stability in human body fluids such as serum, plasma, and urine. Furthermore, many other noncoding RNAs (ncRNAs) such as long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) have shown to be novel biomarkers as well. The aim of this exciting research field is to offer novel tools, allowing translational scientists to develop new strategies for diagnosis, screening, and monitoring of diseases. In this book chapter, the miRandola database and its applications will be introduced. The database offers the possibility to explore information on ncRNAs as noninvasive biomarkers, manually extracted from scientific literature and public available resources.

Entities:  

Keywords:  Biomarkers; Body fluids; Database; MicroRNAs; ncRNAs

Year:  2021        PMID: 33835456     DOI: 10.1007/978-1-0716-1307-8_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR.

Authors:  J Robin Lytle; Therese A Yario; Joan A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

2.  [From zemstvo health officer to academician (on the centenary of the birth of N. A. Marzeev)].

Authors:  M G Shandala; V Ia Kogan
Journal:  Gig Sanit       Date:  1983-10

3.  A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?

Authors:  Leonardo Salmena; Laura Poliseno; Yvonne Tay; Lev Kats; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-07-28       Impact factor: 41.582

4.  Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.

Authors:  Dan Han; Jiangxue Li; Huamin Wang; Xiaoping Su; Jin Hou; Yan Gu; Cheng Qian; Yun Lin; Xiang Liu; Mingyan Huang; Nan Li; Weiping Zhou; Yizhi Yu; Xuetao Cao
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

5.  Switching from repression to activation: microRNAs can up-regulate translation.

Authors:  Shobha Vasudevan; Yingchun Tong; Joan A Steitz
Journal:  Science       Date:  2007-11-29       Impact factor: 47.728

Review 6.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

Review 7.  Revealing protein-lncRNA interaction.

Authors:  Fabrizio Ferrè; Alessio Colantoni; Manuela Helmer-Citterich
Journal:  Brief Bioinform       Date:  2015-06-02       Impact factor: 11.622

8.  miRandola 2017: a curated knowledge base of non-invasive biomarkers.

Authors:  Francesco Russo; Sebastiano Di Bella; Federica Vannini; Gabriele Berti; Flavia Scoyni; Helen V Cook; Alberto Santos; Giovanni Nigita; Vincenzo Bonnici; Alessandro Laganà; Filippo Geraci; Alfredo Pulvirenti; Rosalba Giugno; Federico De Masi; Kirstine Belling; Lars J Jensen; Søren Brunak; Marco Pellegrini; Alfredo Ferro
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

9.  LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1.

Authors:  Yujia Shan; Jia Ma; Yue Pan; Jialei Hu; Bing Liu; Li Jia
Journal:  Cell Death Dis       Date:  2018-06-18       Impact factor: 8.469

10.  miRandola: extracellular circulating microRNAs database.

Authors:  Francesco Russo; Sebastiano Di Bella; Giovanni Nigita; Valentina Macca; Alessandro Laganà; Rosalba Giugno; Alfredo Pulvirenti; Alfredo Ferro
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.